Evidence map›Paper›PMID 34952535›Full record

ArticlePhysics in medicine and biology2022

Deep-learning and radiomics ensemble classifier for false positive reduction in brain metastases segmentation.

Zi Yang, Mingli Chen, Mahdieh Kazemimoghadam, Lin Ma, Strahinja Stojadinovic, Robert Timmerman, Tu Dan, Zabi Wardak, Weiguo Lu, Xuejun Gu

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Deep learning in MRI-guided radiation therapy: A systematic review.Journal of applied clinical medical physics · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Automatically tracking brain metastases after stereotactic radiosurgery.Physics and imaging in radiation oncology · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zi YangDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.ORCID 0000-0003-2653-7757
Mingli ChenDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.
Mahdieh KazemimoghadamDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.ORCID 0000-0001-6561-647X
Lin MaDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.ORCID 0000-0002-5637-8577
Strahinja StojadinovicDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.ORCID 0000-0002-6840-5747
Robert TimmermanDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.
Tu DanDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.
Zabi WardakDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.
Weiguo LuDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.ORCID 0000-0003-3036-7287
Xuejun GuDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.ORCID 0000-0001-6725-6906

Funding

An artificial intelligence-driven distributed stereotactic radiosurgery strategy for multiple brain metastases managementR01CA235723 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GU, XUEJUN, LU, WEIGUO · 2019 to 2024
$2.9M
NCI NIH HHS R01 CA235723
6 · The paper itself

Abstract

Stereotactic radiosurgery (SRS) is now the standard of care for brain metastases (BMs) patients. The SRS treatment planning process requires precise target delineation, which in clinical workflow for patients with multiple (>4) BMs (mBMs) could become a pronounced time bottleneck. Our group has developed an automated BMs segmentation platform to assist in this process. The accuracy of the auto-segmentation, however, is influenced by the presence of false-positive segmentations, mainly caused by the injected contrast during MRI acquisition. To address this problem and further improve the segmentation performance, a deep-learning and radiomics ensemble classifier was developed to reduce the false-positive rate in segmentations. The proposed model consists of a Siamese network and a radiomic-based support vector machine (SVM) classifier. The 2D-based Siamese network contains a pair of parallel feature extractors with shared weights followed by a single classifier. This architecture is designed to identify the inter-class difference. On the other hand, the SVM model takes the radiomic features extracted from 3D segmentation volumes as the input for twofold classification, either a false-positive segmentation or a true BM. Lastly, the outputs from both models create an ensemble to generate the final label. The performance of the proposed model in the segmented mBMs testing dataset reached the accuracy (ACC), sensitivity (SEN), specificity (SPE) and area under the curve of 0.91, 0.96, 0.90 and 0.93, respectively. After integrating the proposed model into the original segmentation platform, the average segmentation false negative rate (FNR) and the false positive over the union (FPoU) were 0.13 and 0.09, respectively, which preserved the initial FNR (0.07) and significantly improved the FPoU (0.55). The proposed method effectively reduced the false-positive rate in the BMs raw segmentations indicating that the integration of the proposed ensemble classifier into the BMs segmentation platform provides a beneficial tool for mBMs SRS management.

Indexed as

Brain NeoplasmsDeep LearningRadiosurgeryHumansMagnetic Resonance ImagingSupport Vector Machinebrain metastasesclassificationstereotactic radiosurgery

Identifiers

PMID34952535
PMCPMC8858586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.